Evidence map›Paper›PMID 31841750›Full record

ArticleDrug and alcohol dependence2020

Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM.

Marjan Javanbakht, Steven Shoptaw, Amy Ragsdale, Ron Brookmeyer, Robert Bolan, Pamina M Gorbach

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Drug and alcohol dependence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Observational
  10. Article
  11. Overamped: Stimulant Use and HIV Pathogenesis.Current HIV/AIDS reports · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marjan JavanbakhtUCLA Fielding School of Public Health, Department of Epidemiology, Los Angeles, CA, United States. Electronic address: javan@ucla.edu.
Steven ShoptawUCLA David Geffen School of Medicine, Department of Family Medicine, Los Angeles, CA, United States.
Amy RagsdaleUCLA Fielding School of Public Health, Department of Epidemiology, Los Angeles, CA, United States.
Ron BrookmeyerUCLA Fielding School of Public Health, Department of Biostatistics, Los Angeles, CA, United States.
Robert BolanLos Angeles LGBT Center, Los Angeles, CA, United States.
Pamina M GorbachUCLA Fielding School of Public Health, Department of Epidemiology, Los Angeles, CA, United States.
Los Angeles LGBT Center · USUniversity of California, Los Angeles · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) U01DA036267 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SHOPTAW, STEVEN J · 2013 to 2024
$20.5M
Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Martha Jane Bailey · 2016 to 2026
$6.9M
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Second Bridge Funding SupplementU24DA044554 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SIMINSKI, SUZANNE M. · 2017 to 2022
$6.8M
NICHD NIH HHS P2C HD041022NIDA NIH HHS U01 DA036267NIDA NIH HHS U24 DA044554NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

backgroundThe objective of this study was to examine depressive symptoms overtime and quantify the variance in symptoms attributable to substance use among a cohort of HIV-positive and HIV-negative men.

methodsParticipants were enrolled in an NIH/NIDA funded cohort, with 534 men resulting in 1,888 visits between August 2014 and June 2018. Participants were between 18 and 45 years, and half were HIV-positive. At baseline and semi-annual visits, information was collected on depressive symptoms, sexual behaviors, and substance use. Changes overtime in symptom scores were evaluated using individual growth curve modeling.

resultsThe average CES-D

conclusionsThe prevalence of depressive symptoms among this cohort of HIV-negative and HIV-positive MSM was high, especially among frequent methamphetamine users. These findings suggest that reducing methamphetamine use may have the potential to reduce depressive symptoms.

Indexed as

AdultCohort StudiesDepressionHIV InfectionsHIV SeropositivityHomosexuality, MaleHumansMaleMethamphetamineMiddle AgedRisk-TakingSubstance-Related DisordersSurveys and QuestionnairesTime FactorsMethamphetamineDepressive symptomsHIVMethamphetamineMSMSubstance use

Identifiers

PMID31841750
PMCPMC6981056
OpenAlexW2991344877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.